Robert C Harland
Overview
Explore the profile of Robert C Harland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
356
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Witkowski P, Anteby R, Olaitan O, Forbes R, Niederhaus S, Ricordi C, et al.
Transplantation
. 2021 Jul;
105(12):e409-e410.
PMID: 34231527
No abstract available.
2.
Witkowski P, Odorico J, Pyda J, Anteby R, Stratta R, Schrope B, et al.
J Clin Med
. 2021 Jul;
10(13).
PMID: 34209541
The Food and Drug Administration (FDA) has been regulating human islets for allotransplantation as a biologic drug in the US. Consequently, the requirement of a biological license application (BLA) approval...
3.
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update
Witkowski P, Philipson L, Kaufman D, Ratner L, Abouljoud M, Bellin M, et al.
Am J Transplant
. 2020 Nov;
21(4):1365-1375.
PMID: 33251712
Islet allotransplantation in the United States (US) is facing an imminent demise. Despite nearly three decades of progress in the field, an archaic regulatory framework has stymied US clinical practice....
4.
Harland R, Klintmalm G, Jensik S, Yang H, Bromberg J, Holman J, et al.
Am J Transplant
. 2019 Sep;
20(1):159-171.
PMID: 31509331
This study assessed the efficacy and safety of the anti-CD40 monoclonal antibody bleselumab (ASKP1240) in de novo kidney transplant recipients over 36 months posttransplant. Transplant recipients were randomized (1:1:1) to...
5.
Kelly A, Smith K, Purvis W, Min C, Weber C, Cooksey A, et al.
Transplantation
. 2018 Aug;
103(1):160-167.
PMID: 30095738
Background: All human islets used in research and for the clinical treatment of diabetes are subject to ischemic damage during pancreas procurement, preservation, and islet isolation. A major factor influencing...
6.
Agrawal N, Echenique I, Meehan S, Limaye A, Cook L, Chang A, et al.
Transpl Int
. 2017 Mar;
30(7):670-678.
PMID: 28295760
Polyomavirus nephropathy (PVN) is a major complication of kidney transplantation. Most reports describe polyomavirus viremia either precedes or is detectable at the time of diagnosis of PVN. This association is...
7.
Dimou F, Mehta H, Adhikari D, Harland R, Riall T, Kuo Y
Surgery
. 2016 Aug;
160(6):1533-1543.
PMID: 27554622
Background: Nonalcoholic steatohepatitis is expected to become the leading indication for liver transplantation. Use of extended criteria donors (ECD) may help with donor allocation in these patients. The objective of...
8.
Torrent D, Maness M, Kachare S, Zink J, Haisch C, Harland R, et al.
J Surg Res
. 2014 Aug;
192(1):1-5.
PMID: 25151468
Background: The Hemodialysis Reliable Outflow (HeRO) vascular access device is a hybrid polytetrafluoroethylene graft-stent construct designed to address central venous occlusive disease. Although initial experience has demonstrated excellent mid-term patency...
9.
Cail J, Huang W, Terasaki P, Everly M, Briley K, Haisch C, et al.
Clin Transpl
. 2014 Aug;
:319-24.
PMID: 25095524
Donor specific human leukocyte antigen (HLA) antibodies (DSA) are a significant cause of allograft failure. However, it has been reported that some DSA negative patients still experience allograft failure. In...
10.
Dieplinger G, Everly M, Rebellato L, Haisch C, Briley K, Bolin P, et al.
Transplantation
. 2014 Jun;
98(10):1097-104.
PMID: 24911039
Background: Many patients develop de novo donor-specific anti-human leukocyte antigen antibodies (dnDSA) after transplantation. Despite development of dnDSA, not all patients will immediately fail. This study analyzes dnDSA intensity and...